Brief: Plx Pharma Q2 Loss Per Share $1.10

PLx Pharma Winddown

09/08/2019 11:52

PLx Pharma Inc  PLXP.O :
    * . REPORTS SECOND QUARTER 2019 RESULTS
    * Q2 LOSS PER SHARE $1.10
    * Q2 REVENUE $200,000
    * Q2 REVENUE ESTIMATE $111,000 -- REFINITIV IBES DATA
    * REMAINS ON TRACK FOR COMMERCIAL LAUNCH OF VAZALORE IN
MID-2020
    * AS OF JUNE 30, 2019, COMPANY HAD CASH AND CASH EQUIVALENTS
OF
$21.3 MILLION

Source text for Eikon:  ID:nGNX8vj2zQ 
Further company coverage:  PLXP.O